Meiogenix and Lesaffre collaborate to improve industrial yeast strains’ performance

June 7, 2016

Meiogenix and Lesaffre enter into a collaboration agreement to develop improved industrial yeast strains using Meiogenix’s recombination technologies. The PhoeniX technology developed by Meiogenix controls the process of natural meiotic recombination and generates efficiently non–GM recombined yeast cells particularly for industrial strains where meiosis is impeded.
read more

Meiogenix and Cambridge University receive a BBSRC grant to unlock plant genetic diversity via epigenetic modifications

April 26, 2016

Meiogenix and the group lead by Ian Henderson at the University of Cambridge have received a grant from the Biotechnology and Biological Sciences Research Council (BBRSC), UK. This grant funds research that aims at elucidating the epigenetic mechanisms that control meiotic recombination. The final goal is to apply these discoveries in crops such as wheat to recombine their natural genetic diversity and to accelerate plant breeding.
read more

Meiogenix Announces a Licensing Agreement with Bayer to apply SpiX technology in crops

April 6, 2016

Meiogenix, a biotech company that develops breeding technologies to unlock the unexplored genetic diversity of organisms, announced today it has signed a collaboration agreement with Bayer’s Crop Science division to apply SpiX technology in crops.
read more

Meiogenix, Announces the Constitution of a Scientific Advisory Board

March 21, 2012

Meiogenix, a genomic biotech company developing a technology that modulates meiotic recombination (SpiX), has announced the constitution of its Scientific Advisory Board. Dr. Alain Nicolas will chair the SAB, and is joined by Prof. Holger Puchta and Prof. Philip Avner.
read more

Meiogenix Applies Its Technology To Generate New Varieties Of Rice

January 28, 2011

Meiogenix and CIRAD signed a collaboration agreement to evaluate the impact of Meiogenix’s SpiX® technology in modulating meiotic homologous recombination in the genome of rice. The research program which will be performed in the laboratory of Dr. Emmanuel Guiderdoni, an expert in rice genomics, could lead to the identification of new natural varieties of rice with high commercial potential.
read more

Meiogenix SAS, A French Genomic Start-up Company, Raises 1,2M€ From Investors

January 8, 2011

Meiogenix SAS, a French start-up biotech company developing a new genomic technology, closed its first round of financing of 1,2M€ from Kurma Biofund, a French venture capital fund focused in Life Sciences.
read more